Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set

被引:1
|
作者
Sharma, Raman [1 ]
Chen, Chao [4 ]
Fita, Ioana-Gabriela [5 ]
Gibson, Rachel A. [2 ]
Jones, Sion [6 ]
Pingle, Anup [8 ]
Rolfe, Katie [3 ]
Sharma, Hema
Bird, Panayota [7 ]
机构
[1] GSK, Clin Pharmacol Modelling & Simulat, Stevenage, Herts, England
[2] GSK, Global Hlth Med R&D, Stevenage, Herts, England
[3] GSK, Biostat, Stevenage, Herts, England
[4] GSK, Clin Pharmacol Modelling & Simulat, Brentford, Middx, England
[5] GSK, Safety Evaluat & Risk Management, Brentford, Middx, England
[6] GSK, Clin Safety & Pharmacovigilance, Brentford, Middx, England
[7] GSK, Global Hlth, Brentford, Middx, England
[8] GSK, Global Hlth Access, Mumbai, Maharashtra, India
关键词
PREVENT RELAPSE; DOUBLE-BLIND; EFFICACY; PRIMAQUINE; TOLERABILITY; REGIMENS; SAFETY; TRIAL;
D O I
10.4103/ijmr.ijmr_405_23
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:204 / 206
页数:3
相关论文
共 50 条
  • [1] Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set Response
    Sharma, Jatin
    Gautam, C. S.
    Singh, Harmanjit
    Singh, Jagjit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2023, 158 (02) : 207 - 210
  • [2] Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax
    Tan, Kathrine R.
    Hwang, Jimee
    JOURNAL OF TRAVEL MEDICINE, 2018, 25
  • [3] Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
    Markus, Miles B.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 989 - 999
  • [4] Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
    Mayence, Annie
    Vanden Eynde, Jean Jacques
    PHARMACEUTICALS, 2019, 12 (03)
  • [5] Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
    Suh, Jiyeon
    Kim, Jung Ho
    Kim, Jong-Dae
    Kim, Changsoo
    Choi, Jun Yong
    Lee, Jeehyun
    Yeom, Joon-Sup
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (27)
  • [6] The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
    Watson, James A.
    Commons, Robert J.
    Tarning, Joel
    Simpson, Julie A.
    Cuentas, Alejandro Llanos
    Lacerda, Marcus V. G.
    Green, Justin A.
    Koh, Gavin C. K. W.
    Chu, Cindy S.
    Nosten, Francois H.
    Price, Richard N.
    Day, Nicholas P. J.
    White, Nicholas J.
    ELIFE, 2022, 11
  • [7] Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
    Sharma, Raman
    Chen, Chao
    Tan, Lionel
    Rolfe, Katie
    Fita, Ioana-Gabriela
    Jones, Sion
    Pingle, Anup
    Gibson, Rachel A.
    Goyal, Navin
    Sharma, Hema
    Bird, Panayota
    ELIFE, 2024, 13
  • [8] Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
    Quinn, Jane C.
    McCarthy, Stuart
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1875 - 1875
  • [9] Failure to radical cure in Plasmodium vivax malaria
    Garcia, Julian
    Seijo, Agustin
    Benchetrit, Andres
    Couto, Esteban
    Echazarreta, Sofia
    Lloveras, Susana
    Orduna, Tomas
    REVISTA CHILENA DE INFECTOLOGIA, 2016, 33 (04): : 468 - 471
  • [10] Improving the Radical Cure of Plasmodium vivax Malaria
    Price, Ric N.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2014, 91 (01): : 3 - 4